Hjem › Brystkreft › Michigan › Ann Arbor
Kliniske studier for Brystkreft i Ann Arbor, MI
27 studier for Brystkreft søker deltakere på steder i og rundt Ann Arbor (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
RekruttererFase 3
- University of Michigan, Ann Arbor
A Study of PHST001 in Advanced Solid Tumors
RekruttererFase 1
- University of Michigan Rogel Cancer Center, Ann Arbor
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 7 mi unna
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi unna
- og 4 flere
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
RekruttererFase 1/2
- University of Michigan, Ann Arbor
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
RekruttererFase 2
- University of Michigan Rogel Cancer Center, Ann Arbor
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
RekruttererFase 3
- Clinical Trial Site, Ann Arbor
A Phase 1/1b Study of IAM1363 in HER2 Cancers
RekruttererFase 1
- University of Michigan, Ann Arbor
Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial
RekruttererFase 3
- Trinity Health IHA - Obstetrics and Gynecology West Arbor, Ann Arbor
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
RekruttererObservasjonsstudie
- Trinity Health, Ann Arbor
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RekruttererFase 3
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- University of Michigan Rogel Cancer Center, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 7 mi unna
- og 6 flere
E-Mindfulness Approaches for Living After Breast Cancer
RekruttererFase 3
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
RekruttererFase 2Frivillige helsepersonell ønskes velkommen
- University of Michigan Rogel Cancer Center, Ann Arbor
Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
RekruttererFase 2
- University of Michigan Rogel Cancer Center, Ann Arbor
Study of Ribociclib Administered Concurrently With Postoperative Radiation Therapy in Patients With High-Risk, HR+/HER2- Breast Cancer
RekruttererFase 1
- University of Michigan, Ann Arbor
Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer
RekruttererFase 4
- University of Michigan Rogel Cancer Center, Ann Arbor
Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial
RekruttererFase 2
- University of Michigan Comprehensive Cancer Center, Ann Arbor
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
RekruttererFase 3
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- University of Michigan Rogel Cancer Center, Ann Arbor
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi unna
- og 5 flere
Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer
RekruttererFase 1/2
- Trinity Health, Ypsilanti · 7 mi unna
CIPN Decision Aid for the Improvement of Chemotherapy Decision Making in Patients With Breast Cancer
Rekrutterer
- University of Michigan Comprehensive Cancer Center, Ann Arbor
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RekruttererObservasjonsstudie
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients
Rekrutterer
- University of Michigan Comprehensive Cancer Center, Ann Arbor
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Ann Arbor
The Cancer of the Pancreas Screening-5 CAPS5)Study
RekruttererFase 3
- University of Michigan, Ann Arbor
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
RekruttererFase 3
- Saint Joseph Mercy Hospital, Ann Arbor
- University of Michigan Comprehensive Cancer Center, Ann Arbor
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi unna
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
RekruttererFase 1/2
- University of Michigan, Ann Arbor
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
RekruttererFase 1
- University of Michigan, Ann Arbor
CtDNA Based MRD Testing for NAC Monitoring in TNBC
RekruttererObservasjonsstudie
- Trinity Health-Michigan, Ypsilanti · 7 mi unna
Brystkreft-studier i andre byer
- New York City, NY136 studier
- Houston, TX126 studier
- Boston, MA112 studier
- Nashville, TN81 studier
- Los Angeles, CA73 studier
- Edison, NJ68 studier
- St. Louis, MO64 studier
- Queens, NY64 studier
- Durham, NC64 studier
- Chicago, IL59 studier
- Philadelphia, PA56 studier
- Dallas, TX55 studier
Andre studier i Ann Arbor
- Prostatakreft27 studier
- Ikke-småcellet lungekreft26 studier
- Kreft (alle typer)25 studier
- Lungekreft23 studier
- Kolorektal kreft23 studier
- Hjertesvikt22 studier
- Akut myelogen leukemi17 studier
- Kardiovaskulær sykdom16 studier
- Pankreaskreft14 studier
- Melanom12 studier
- Slag12 studier
- Plateepitelcancer i hode og hals12 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.